Extracorporeal Membrane Oxygenation (ECMO) in an Infant with COVID-19: A Case Report with Literature Review

  • Authors: Falsaperla R.1, Vaccalluzzo M.2, Collotta A.3, Ruggieri M.4, Agati S.5
  • Affiliations:
    1. Neonatal Intensive Care Unit and Neonatal Accompaniment Unit, Azienda Ospedaliero-Universitaria Policlinico "Rodolico-San Marco", San Marco Hospital, University of Catania
    2. Medicine and Surgery, University of Catania
    3. Postgraduate Training Program in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania
    4. Unit of Rare Diseases of the Nervous System in Childhood, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry,, University of Catania
    5. Cardiovascular Department, Mediterranean Pediatric Cardiology Center, Bambino Gesù Children's Hospital
  • Issue: Vol 20, No 3 (2024)
  • Pages: 370-374
  • Section: Medicine
  • URL: https://journals.eco-vector.com/1573-3963/article/view/645652
  • DOI: https://doi.org/10.2174/1573396320666230417103203
  • ID: 645652

Cite item

Full Text

Abstract

Background:SARS-CoV-2 infection tends to be lethal to the elderly population. How- ever, sometimes children are also involved.

Case Presentation:We present the case of a female infant with a corrected gestational age of 39 weeks and 4 days with severe COVID-19 pneumonia and co-infection of Klebsiella pneumoniae that was supported with extracorporeal membrane oxygenation (ECMO).

Results:We reported the clinical case and reviewed the literature articles on ECMO and Covid-19 in infants and children up to two years of age

Conclusion:It is crucial to be aware of certain risk factors (severe prematurity, coinfection), which, when linked to SARS-CoV-2 infection, must immediately alert us to the possible criticality of the clinical condition of patients, as highlighted by our own clinical case

About the authors

Raffaele Falsaperla

Neonatal Intensive Care Unit and Neonatal Accompaniment Unit, Azienda Ospedaliero-Universitaria Policlinico "Rodolico-San Marco", San Marco Hospital, University of Catania

Author for correspondence.
Email: info@benthamscience.net

Marco Vaccalluzzo

Medicine and Surgery, University of Catania

Email: info@benthamscience.net

Ausilia Collotta

Postgraduate Training Program in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania

Email: info@benthamscience.net

Martino Ruggieri

Unit of Rare Diseases of the Nervous System in Childhood, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry,, University of Catania

Email: info@benthamscience.net

Salvatore Agati

Cardiovascular Department, Mediterranean Pediatric Cardiology Center, Bambino Gesù Children's Hospital

Email: info@benthamscience.net

References

  1. WHO. Coronavirus disease (COVID-19) Available From: https://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19
  2. World Health Organization. COVID-19 disease in children and adolescents. Sci Br 2021; (September): 1-10.
  3. Hu B, Huang S, Yin L. The cytokine storm and COVID‐19. J Med Virol 2021; 93(1): 250-6. Available From: http://www.ncbi.nlm.nih.gov/pubmed/32592501 doi: 10.1002/jmv.26232 PMID: 32592501
  4. Singh AK, Oks M, Husk G, et al. Impact of timing of tocilizumab use in hospitalized patients with SARS-CoV-2 infection. Respir Care 2021; 66(12): 1805-14. Available From: https://rc.rcjournal.com/lookup/doi/10.4187/respcare.08779 doi: 10.4187/respcare.08779 PMID: 34548407
  5. Mallalieu NL, Wimalasundera S, Hsu JC, et al. Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: Results from an open-label phase 1 clinical trial. Pediatr Rheumatol Online J 2019; 17(1): 57. Available From: https://www.ncbi.nlm.nih.gov/pubmed/31438986 doi: 10.1186/s12969-019-0364-z PMID: 31438986
  6. Velasco Puyó P, Moreno L, Díaz de Heredia C, Rivière JG, Soler Palacín P. Tocilizumab in a child with acute lymphoblastic leukemia and cytokine release syndrome associated with COVID-19. Ann Pediatr 2020; 93(2): 132-3. Available From: https://www.linkinghub.elsevier.com/retrieve/pii/S1695403320301806 doi: 10.1016/j.anpedi.2020.05.002
  7. Murphy DA, Hockings LE, Andrews RK, et al. Extracorporeal membrane oxygenation-hemostatic complications. Transfus Med Rev 2015; 29(2): 90-101. Available From: http://www.ncbi.nlm.nih.gov/pubmed/25595476 doi: 10.1016/j.tmrv.2014.12.001 PMID: 25595476
  8. Thomas J, Kostousov V, Teruya J. Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation Semin Thromb Hemost 2018; 44(1): 020-9. Available From: https://www.ncbi.nlm.nih.gov/pubmed/28898902 doi: 10.1055/s-0037-1606179 PMID: 28898902
  9. Cavayas YA, del Sorbo L, Fan E. Intracranial hemorrhage in adults on ECMO. Perfusion 2018; 33 (Suppl. 1): 42-50. Available From: https://www.ncbi.nlm.nih.gov/pubmed/29788836 doi: 10.1177/0267659118766435 PMID: 29788836
  10. ELSO. Registry Dashboard of ECMO-Supported COVID-19 Patient Data.. Available From: https://www.elso.org/Registry/FullCOVID-19RegistryDashboard.aspx
  11. Götzinger F, Santiago-García B, Noguera-Julián A, Lanaspa M, Lancella L, Calò Carducci FI, et al. COVID-19 in children and adolescents in Europe: A multinational, multicentre cohort study. Lancet Child Adolesc Heal Lancet Child Adolesc Heal 2020; 4(9): 653-61. Available From: http://www.ncbi.nlm.nih.gov/pubmed/32593339
  12. Meyts I, Bucciol G, Quinti I, et al. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study. J Allergy Clin Immunol 2021; 147(2): 520-31. Available From: http://www.ncbi.nlm.nih.gov/pubmed/32980424 doi: 10.1016/j.jaci.2020.09.010 PMID: 32980424
  13. Cura Yayla BC, Özsürekçi Y, Aykaç K, et al. Characteristics and management of children with COVID-19 in Turkey. Balkan Med J 2020; 37(6): 341-7. Available From: http://www.ncbi.nlm.nih.gov/pubmed/32865382 doi: 10.4274/balkanmedj.galenos.2020.2020.7.52 PMID: 32865382
  14. Cicek M, Onalan MA, Yurtseven N. COVID-19 and ECMO support after neonatal congenital heart surgery: A case report. Cardiol Young 2022; 32(1): 150-3. Available From: http://www.ncbi.nlm.nih.gov/pubmed/34112275 doi: 10.1017/S1047951121002511 PMID: 34112275
  15. Di Nardo M, Hoskote A, Thiruchelvam T, et al. Extracorporeal membrane oxygenation in children with coronavirus disease 2019: Preliminary report from the collaborative European chapter of the extracorporeal life support organization prospective survey. ASAIO J 2021; 67(2): 121-4. Available From: http://www.ncbi.nlm.nih.gov/pubmed/33009172 doi: 10.1097/MAT.0000000000001309 PMID: 33009172
  16. Sainathan S, Heal ME, Frantz E, Johnston P, Smith R, Sharma M. Use of VA ECMO and percutaneous palliation of ductal dependent co-arctation in a neonate with trisomy 21 and COVID-19 pneumonia. Indian J Thorac Cardiovasc Surg 2021; 37(6): 698-701. Available From: http://www.ncbi.nlm.nih.gov/pubmed/34054231
  17. Oualha M, Bendavid M, Berteloot L, et al. Severe and fatal forms of COVID-19 in children. Arch Pediatr 2020; 27(5): 235-8. Available From: http://www.ncbi.nlm.nih.gov/pubmed/32518045 doi: 10.1016/j.arcped.2020.05.010 PMID: 32518045
  18. Nabialek TJ, Puppala NK, Riordan A, Ramaraj R, Duong P, Guerrero R. Successful Management of a COVID-19 Positive Infant With Transposition of the Great Arteries. World J Pediatr Congenit Heart Surg 2021; 12(4): 554-6. Available From: http://www.ncbi.nlm.nih.gov/pubmed/33736537 doi: 10.1177/21501351211000687 PMID: 33736537
  19. Lee H, Choi S, Park JY, et al. Analysis of Critical COVID-19 Cases Among Children in Korea. J Korean Med Sci 2022; 37(1): e13. Available From: http://www.ncbi.nlm.nih.gov/pubmed/34981683 doi: 10.3346/jkms.2022.37.e13 PMID: 34981683
  20. Alfraij A, Bin Alamir AA, Al-Otaibi AM, et al. Characteristics and outcomes of coronavirus disease 2019 (COVID-19) in critically ill pediatric patients admitted to the intensive care unit: A multicenter retrospective cohort study. J Infect Public Health 2021; 14(2): 193-200. Available From: http://www.ncbi.nlm.nih.gov/pubmed/33486375 doi: 10.1016/j.jiph.2020.12.010 PMID: 33486375
  21. Otto WR, Geoghegan S, Posch LC, et al. The Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Healthcare Network in the United States. J Pediatric Infect Dis Soc 2020; 9(5): 523-9. Available From: http://www.ncbi.nlm.nih.gov/pubmed/32559282 doi: 10.1093/jpids/piaa074 PMID: 32559282
  22. Derespina KR, Kaushik S, Plichta A, et al. Clinical manifestations and outcomes of critically ill children and adolescents with coronavirus disease 2019 in New York City. J Pediatr 2020; 226: 55-63. e2. Available From: http://www.ncbi.nlm.nih.gov/pubmed/32681989 doi: 10.1016/j.jpeds.2020.07.039 PMID: 32681989
  23. Burger M, Moore M, Wilburn J. Case Report: Pediatric patient with COVID-19 and multisystem inflammatory syndrome in children. Clin Pract Cases Emerg Med 2020; 4(4): 513-6. Available From: http://www.ncbi.nlm.nih.gov/pubmed/33217259 doi: 10.5811/cpcem.2020.8.48376 PMID: 33217259
  24. Ebach F, Hainmann I, Eis-Hübinger AM, et al. Successful ECMO therapy in a child with COVID‐19‐associated ARDS and acute lymphoblastic leukemia. Pediatr Blood Cancer 2021; 68(9): e29100. Available From: http://www.ncbi.nlm.nih.gov/pubmed/34022118 doi: 10.1002/pbc.29100 PMID: 34022118

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers